Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Scheffel

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine|January 11, 1991
Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptorsY Uno, K Matsumura, U Scheffel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 1991
In vitro and in vivo characterization of 4-[125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heartK Matsumura, Y Uno, U Scheffel, et al.
Life Sciences|January 1, 1994
(+)-[C-11]-cis-N-benzyl-normetazocine: a selective ligand for sigma receptors in vivoJ L Musachio, U Scheffel, M Stathis, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 11, 1991
Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PETM Suehiro, A A Wilson, U Scheffel, et al.
Synapse (New York, N.Y.)|June 1, 1996
Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transportersU Scheffel, C Steinert, S E Kim, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|July 11, 1992
Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2',4'-dichlorophenyl)-indanamine (cis-[11C]DDPI)M Suehiro, U Scheffel, R F Dannals, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1993
A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652ZM Suehiro, U Scheffel, R F Dannals, et al.
Nuclear Medicine and Biology|January 11, 2000
[11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptorsH T Ravert, W B Mathews, J L Musachio, et al.
Neuroreport|November 1, 1992
Dopamine transporter imaging with novel, selective cocaine analogsU Scheffel, R F Dannals, D F Wong, et al.
Psychopharmacology|June 1, 1995
Rate of binding of various inhibitors at the dopamine transporter in vivoM Stathis, U Scheffel, S Z Lever, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine|January 11, 1991
Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptorsY Uno, K Matsumura, U Scheffel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 1991
In vitro and in vivo characterization of 4-[125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heartK Matsumura, Y Uno, U Scheffel, et al.
Life Sciences|January 1, 1994
(+)-[C-11]-cis-N-benzyl-normetazocine: a selective ligand for sigma receptors in vivoJ L Musachio, U Scheffel, M Stathis, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 11, 1991
Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PETM Suehiro, A A Wilson, U Scheffel, et al.
Synapse (New York, N.Y.)|June 1, 1996
Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transportersU Scheffel, C Steinert, S E Kim, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|July 11, 1992
Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2',4'-dichlorophenyl)-indanamine (cis-[11C]DDPI)M Suehiro, U Scheffel, R F Dannals, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1993
A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652ZM Suehiro, U Scheffel, R F Dannals, et al.
Nuclear Medicine and Biology|January 11, 2000
[11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptorsH T Ravert, W B Mathews, J L Musachio, et al.
Neuroreport|November 1, 1992
Dopamine transporter imaging with novel, selective cocaine analogsU Scheffel, R F Dannals, D F Wong, et al.
Psychopharmacology|June 1, 1995
Rate of binding of various inhibitors at the dopamine transporter in vivoM Stathis, U Scheffel, S Z Lever, et al.
Pageof 10